Cannabis Law Report

JULY 20, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 Separately, from a social point of view, as of 2021, 49% of adults have tried marijuana in the US, which is approximately 162,678,600 Americans.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 Separately, from a social point of view, as of 2021, 49% of adults have tried marijuana in the US, which is approximately 162,678,600 Americans.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JANUARY 19, 2022

The US Food and Drug Administration (FDA) and potentially the Drug Enforcement Agency (DEA), could bring enforcement action against producers of some of these intoxicating products if they so choose. Safety concerns. There is no indication that any enforcement action is imminent. Key Topics Covered: Executive summary. Legal framework.

Hemp 52

Hemp DEA Cannabinoids Topical 52

Cannabis Law Report

AUGUST 27, 2021

ACS Laboratory Will Grant its Safety Seal to Any Product Testing Beyond the Minimum for a Full Panel of Tests. 24, 2021 /PRNewswire/ — ACS Laboratory , the largest state-of-the-art testing facility in cannabis and hemp testing in the eastern U.S., BOCA RATON, Fla. , Aug. BOCA RATON, Fla. , Aug.

Cannabinoids 98

Cannabinoids Programs Safety Hemp 98

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] DEA and the Controlled Substances Act. Mitchell et al.,

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 28, 2022

And Denver voters by a narrow margin in early 2021 approved Ordinance 301 to decriminalize the use and possession of mushrooms that contain psilocybin, a hallucinogenic compound. To sign up for a free subscription to Food Safety News, click here.). Blog: Food Safety News. His career as a…. Show more .

Legalization 52

Legalization Decriminalization Food Safety 52

SpeedWeed

JULY 21, 2021

The release indicated that preliminary data shows 418 overdose deaths in the first three months of 2021—compared to 378 overdose deaths in the first three months of 2020. Of the 418 overdose deaths in 2021, 46 percent (191) of those deaths are linked to fentanyl. Even the DEA admits it. Police departments in Kingsland and St.

DEA 52

DEA Dispensary Vaping Data 52

Cannabis Law Report

JULY 9, 2021

In June 2021, similar measures were passed in Connecticut and Texas, where medical research on psilocybin is now also legal on a statewide level. Joyce Cutler, Texas the Latest State to Legalize Psychedelic Medical Research, BLOOMBERG LAW (June 23, 2021), available at [link]. Drug Enforcement Agency (“DEA”). 21-70544, Dkt.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JUNE 16, 2021

Hemp-derived Delta-8 THC is having a big moment in 2021 in terms of popularity and, most recently, in terms of concerns over legality, safety, and accuracy. If you feel like you’ve been catching a lot of Delta-8 THC content in the media lately, those aren’t just your social media apps hacking your brain.

THC 117

THC Hemp Media Data 117

Cannabis Law Report

JULY 23, 2021

On Wednesday, July 14, 2021 Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) released draft legislation titled the Cannabis Administration and Opportunity Act. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF).

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

FEBRUARY 28, 2022

568, 569 (2021) (describing the historical use of psychedelics and the use of validated psychological instruments to measure their subjective effects, which include feelings of unity or connectedness, feelings of reverence, altered perception of space and time, and feelings of love or peace). 9, 2021), [link] [ [link] ]. 10 × 10.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JULY 30, 2021

On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). Industry stakeholders have until September 1, 2021 to provide feedback. [co-author: Jace Pohlman].

Hemp 105

Hemp Law Seed-To-Sale Food 105

SpeedWeed

APRIL 1, 2021

March 31, 2021. As federal and state governments tackle the legalization of hemp as a distinct product from cannabis, the safety of the products produced from hemp isn’t getting the same attention as those produced from THC-based cannabis. Presented By. This article was contributed by SC Labs, a Leafly Certified Labs partner.

THC 52

THC Hemp CBD Vaping 52

Cannabis Law Report

SEPTEMBER 23, 2021

The FDA and CDC each issued warning notices to the public regarding delta-8 THC products on September 14, 2021, many of which are marketed as hemp products (and include some non-obvious references to other novel cannabinoids that may have similar effects and marketing).

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

NOVEMBER 11, 2021

11 November 2021. On November 3, 2021, New York’s Cannabis Control Board (CCB) held its third public meeting during which it made additional progress in developing the regulatory landscape contemplated by the Marijuana Regulation and Taxation Act (MRTA). by Joseph W. Lippes Mathias Wexler Friedman.

Programs 52

Programs Hemp Supply Chain Seed-To-Sale 52

Cannabis Law Report

JUNE 1, 2021

Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results. Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Fourth Quarter Fiscal 2021 Financial Summary. (in Fiscal Year 2021 Financial Summary. (in Net revenue. 2,800) bps.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

MAY 25, 2022

The court also considered Boyd Street’s counterarguments that (1) DEA has interpreted the 2018 Farm Bill as inapplicable to delta-8 THC due to its method of manufacture and (2) Congress never intended for the Act to legalize any psychoactive substance. as opposed to delta-8 THC or total THC (i.e.,

THC 52

THC Legalization Hemp Concentrates 52

Dykema (Cannabis Law Blog)

SEPTEMBER 20, 2021

Limits on who could obtain licenses prior to December 6, 2021, (e.g., Marihuana Safety Compliance Facility. These licensees must secure registration from the DEA within 90 days of being issued their MRA license. MMFLA licensees) would be deleted. Marihuana Event Organizer. Marihuana Microbusiness. Marihuana Processor.

Events 63

Events Education Consumption DEA 63

Cannabis Law Report

NOVEMBER 2, 2021

Oracle wrote 21 October 2021. Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? At present, with almost no regulation over the industry, there is a definite risk of what chemist and hemp safety expert Dr. Matthew Curran describes to Refinery29 as “kitchen chemistry.” Methodology.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JUNE 4, 2021

The legal cannabis industry is expected to exceed $40 billion in 2021 and CBD sales should reach $5 billion. However, Delta 8-THC is explicitly listed on the DEA 7370 Controlled Substance list, so it’s hard to imagine the cases ending in any other way than saying Delta 8-THC should be regulated like cannabis. . .

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Project CBD

AUGUST 23, 2023

8 Safety Issues Associated with Synthetic Cannabinoids This new generation of designer drugs is reminiscent of “Spice,” “K2,” and other synthetic cannabinoids that emerged in the illicit drug market in the early 2000s. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. That power is typically delegated to the DEA.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Veriheal

AUGUST 31, 2020

and farmers are required to have their crops tested at various labs registered with the Drug Enforcement Administration (DEA), but there are not enough labs to meet the demand for testing. . Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

SEPTEMBER 7, 2021

There was no testing information, no information about the manufacturer, no product safety assurance whatsoever. . Drug Enforcement Administration (DEA) recently moved to counter that argument. . DEA’s July 2021 update. And that could have a major impact on product safety. . Not a whole lot. But the U.S.

Vaping 52

Vaping Oil DEA Packaging 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) today announces its financial results for the first quarter fiscal 2022 ended June 30, 2021.

Vaping 105

Vaping Research and Development Data Business 105

Veriheal

FEBRUARY 21, 2022

The armored car was driving into Barstow via a Mojave Desert freeway back in November 2021. The most recent cash seizures come after Empyreal’s previous run-ins with law enforcement in early 2021, forcing the company to ask a federal court to return the funds. Now, the company is stepping up its game.

Dispensary 113

Dispensary Business Legalization DEA 113

Cannabis Law Report

APRIL 13, 2022

Novamind (Trailing 4 quarters ended December 31, 2021). Combines Novamind’s distinguished clinical research site management capabilities with Numinus Bioscience’s bioanalytical laboratory expertise, resulting in a comprehensive clinical research offering. Novamind’s U.S. Numinus (Trailing 4 quarters ended Nov. Gross Profit.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

JUNE 8, 2021

Currently Hemp Acres has 3000 acres under contract for 2021 production and anticipates contracting 10,000 acres in 2022. Requiring all delta-8 products to have a Drug Enforcement Administration (DEA) lab report by a third party testing company. Ordering all delta-8 products to undergo testing for residual solvents.

Hemp 102

Hemp Seed-To-Sale Food Research and Development 102

Veriheal

FEBRUARY 1, 2021

The filing is backed by MAPS (Multidisciplinary Association for Psychedelic Studies) and calls on the DEA to answer a four-year-old filing requesting approval of his application to become a federally registered marijuana cultivator. Back in 2016, the DEA said they were starting the process of approving “additional marijuana cultivators.”

DEA 63

DEA Therapy Cultivation Media 63

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Advocates for marijuana march in New York at the annual NYC Cannabis Parade, New York NY USA-May 1, 2021 (Shutterstock). Who discovered THC?

THC 98

THC Research and Development Cannabinoids CBD 98

SMPL

FEBRUARY 11, 2020

President Trump proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference as part of his fiscal year 2021 budget plan released on Monday. Questions remain regarding the safety of these compounds,” it continued. through regulations and guidance.”. “In

Research and Development 40

Research and Development Legalization Marijuana Programs 40

Cannabis Law Report

AUGUST 5, 2021

Aug 4, 2021 . As everyone in the cannabis industry now knows, on July 14, 2021, Senate Majority Leader Chuck Schumer (D-NY) introduced the long awaited proposed Cannabis Administration and Opportunity Act , weighing in at 163 pages. There will also be a role for the Treasury and the Consumer Product Safety Commission.

Banking 111

Banking Vaping Education DEA 111

Cannabis Law Report

JULY 14, 2021

— Ron Wyden (@RonWyden) July 14, 2021. July 14, 2021 Friends, Today, we are saying, “The days of federal prohibition are numbered.” Date: July 14, 2021. . Additionally, revenue generated by federal taxes will support restorative justice and public health and safety research. What do all the commentators think.

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

SEPTEMBER 29, 2021

Many producers expressed concerns that the DEA’s interim final rule would criminalize the processing of hemp extracts. The bill would also get rid of the USDA’s requirement that only DEA laboratories can test hemp products. There are currently zero DEA registered labs in my home state and [only] one in New England,” Pingree said.

Hemp 52

Hemp Banking Legislation Policy 52

The Joint Blog

JUNE 2, 2020

Trump again tried to strike the policy to protect states’ rights on medical marijuana from the fiscal year 2021 proposed budget plan he released in February 2020. The issue of legalization is left to the state, taking the health and safety of the public into account. During her speech on Feb. Tulsi Gabbard Rep.

Decriminalization 29

Decriminalization Recreational Advocacy Policy 29